12-week Efficacy of Indacaterol
Public ClinicalTrials.gov record NCT01072448. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Treatment, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Once Daily Indacaterol in Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 12-week study evaluated the efficacy and safety of indacaterol versus placebo.
Study identification
- NCT ID
- NCT01072448
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2010 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Aug 19, 2011
2010
United States locations
- U.S. sites
- 62
- U.S. states
- 29
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigator Site | Peoria | Arizona | 85381 | — |
| Novartis Investigator Site | Pine Bluff | Arkansas | 71603 | — |
| Novartis Investigator Site | Buena Park | California | 90620 | — |
| Novartis Investigator Site | Encinitas | California | 92024 | — |
| Novartis Investigator Site | Fountain Valley | California | 92708 | — |
| Novartis Investigator Site | Los Angeles | California | 90015 | — |
| Novartis Investigator Site | San Diego | California | 92103 | — |
| Novartis Investigator Site | San Diego | California | 92120 | — |
| Novartis Investigator Site | Temecula | California | 92591 | — |
| Novartis Investigator Site | Torrance | California | 90505 | — |
| Novartis Investigator Site | Walnut Creek | California | 94598 | — |
| Novartis Investigator Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Port Orange | Florida | 32127 | — |
| Novartis Investigative Site | Sarasota | Florida | 34233 | — |
| Novartis Investigative Site | Tamarac | Florida | 33321 | — |
| Novartis Investigator Site | Couer D'Alene | Idaho | 83814 | — |
| Novartis Investigator Site | Champaign | Illinois | 61820 | — |
| Novartis Investigator Site | Downers Grove | Illinois | 60515 | — |
| Novartis Investigative Site | River Forest | Illinois | 60305 | — |
| Novartis Investigator Site | Skokie | Illinois | 60076 | — |
| Novartis Investigator Site | Springfield | Illinois | 62703 | — |
| Novartis Investigative site | Lexington | Kentucky | 40504 | — |
| Novartis Investigator Site | Covington | Louisiana | 70433 | — |
| Novartis Investigator Site | Metaire | Louisiana | 70002 | — |
| Novartis Investigative Site | Bangor | Maine | 04401 | — |
| Novartis Investigative Site | Columbia | Maryland | 21044 | — |
| Novartis Investigative Site | Clarkston | Michigan | 48346 | — |
| Novartis Investigative Site | Flint | Michigan | 48532 | — |
| Novartis Investigative Site | Livonia | Michigan | 48152 | — |
| Novartis Investigative Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Plymouth | Minnesota | 55441 | — |
| Novartis Investigator Site | Florissant | Missouri | 63033 | — |
| Novartis Investigator Site | Ozark | Missouri | 65721 | — |
| Novartis Investigator Site | St Louis | Missouri | 63117 | — |
| Novartis Investigative Site | Missoula | Montana | 59808 | — |
| Novartis Investigator Site | Bellevue | Nebraska | 68123 | — |
| Novartis Investigator Site | Lincoln | Nebraska | 68516 | — |
| Novartis Investigator Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigator Site | Henderson | Nevada | 89014 | — |
| Novartis Investigator Site | Pahrump | Nevada | 89048 | — |
| Novartis Investigative Site | New Brunswick | New Jersey | 08902 | — |
| Novartis Investigative Site | Ocean City | New Jersey | 07712 | — |
| Novartis Investigative Site | Rochester | New York | 14618 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28209 | — |
| Novartis Investigative Site | Salisbury | North Carolina | 28144 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45231 | — |
| Novartis Investigator Site | Medford | Oregon | 97504 | — |
| Novartis Investigative Site | Beaver | Pennsylvania | 15009 | — |
| Novartis Investigative Site | Erie | Pennsylvania | 16506 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15221 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243 | — |
| Novartis Investigative Site | Gaffney | South Carolina | 29340 | — |
| Novartis Investigative site | Greer | South Carolina | 29651 | — |
| Novartis Investigative Site | Seneca | South Carolina | 29678 | — |
| Novartis Investigative Site | Johnson City | Tennessee | 37601 | — |
| Novartis Investigator Site | Corsicana | Texas | 75110 | — |
| Novartis Investigator Site | Fort Worth | Texas | 76109 | — |
| Novartis Investigator Site | Salt Lake City | Utah | 84107 | — |
| Novartis Investigator Site | Abingdon | Virginia | 24210 | — |
| Novartis Investigative Site | Newport News | Virginia | 23606 | — |
| Novartis Investigator Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01072448, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01072448 live on ClinicalTrials.gov.